Estrogen-induced disruption of neonatal porcine uterine development alters adult uterine function.
In the pig, estradiol-17beta valerate (EV) exposure from birth (Postnatal Day [PND] 0) disrupts estrogen receptor-alpha (ER)-dependent uterine development and increases embryo mortality in adults. To determine effects of neonatal EV exposure on adult uterine morphology and function, 36 gilts received corn oil (CO) or EV from PND 0 to PND 13. Cyclic and pregnant (PX) adults from each treatment group were hysterectomized on Day 12 after estrus/mating. Treatment and pregnancy effects were determined for uterine weight and horn volume, uterine luminal fluid (ULF) protein and estradiol content, endometrial incorporation of 3H-leucine (3H-Leu) into nondialyzable product, and endometrial mRNA levels for ER, progesterone receptor (PR), uteroferrin (UF), retinol-binding protein (RBP), and keratinocyte growth factor (KGF). Adults cycled normally and had similar numbers of corpora lutea. Uteri of PX gilts contained tubular/filamentous conceptuses, and ULF estradiol content was unaffected by treatment. However, pregnancy increased uterine weight and size only in CO gilts (Treatment x Status, P < 0.01). Treatment reduced ULF protein content (P < 0.01), endometrial 3H-Leu incorporation (P < 0.05), and the pregnancy-associated increase in ULF protein (Treatment x Status, P < 0.01). Treatment did not affect endometrial ER or PR mRNA levels but attenuated the pregnancy-associated increase in UF mRNA (Treatment x Status; P < 0.01), increased RBP (P < 0.10), and decreased KGF mRNA levels (P < 0.05). These results establish that transient postnatal estrogen exposure affects porcine uterine responsiveness to potentially embryotrophic signals and that estrogen-sensitive postnatal uterine organizational events are determinants of uterine size and functionality.
Tarleton
Becky J
BJ
Departments of Animal Sciences, auburn University, Auburn, Alabama 36849-5415, USA.
Braden
Tim D
TD
Wiley
Anne A
AA
Bartol
Frank F
FF
D000375:Aging / Q000502:physiology; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development*; D001826:Body Fluids / Q000737:chemistry; D003338:Corpus Luteum / Q000033:anatomy & histology; D004334:Drug Administration Schedule; D004717:Endometrium / Q000378:metabolism; D004958:Estradiol / Q000008:administration & dosage* / Q000032:analysis; D005260:Female; D066298:In Vitro Techniques; D007930:Leucine / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011506:Proteins / Q000032:analysis; D012333:RNA, Messenger / Q000378:metabolism; D013552:Swine; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology*
D011506:Proteins; D012333:RNA, Messenger; D004958:Estradiol; D007930:Leucine